2016
DOI: 10.1111/jphp.12666
|View full text |Cite
|
Sign up to set email alerts
|

A randomized two-way crossover bioequivalence study in healthy adult volunteers of paediatric zidovudine/lamivudine/nevirapine fast-disintegrating fixed-dose combination tablet

Abstract: The developed FDC tablet is bioequivalent to the reference product.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…This finding is not surprising, given that HBCR allows for the enrollment of patients who are unable to travel, a common reason given for lack of participation in CBCR. 44 , 45 , 46 However, this finding is important, given the recent nationwide increase in referrals to HBCR that occurred after the unexpected widespread closure of CBCR programs following the onset of the COVID-19 pandemic and the subsequent call from medical societies to continue to increase participation in HBCR in all eligible patients in the current pandemic era. 47 , 48 …”
Section: Discussionmentioning
confidence: 99%
“…This finding is not surprising, given that HBCR allows for the enrollment of patients who are unable to travel, a common reason given for lack of participation in CBCR. 44 , 45 , 46 However, this finding is important, given the recent nationwide increase in referrals to HBCR that occurred after the unexpected widespread closure of CBCR programs following the onset of the COVID-19 pandemic and the subsequent call from medical societies to continue to increase participation in HBCR in all eligible patients in the current pandemic era. 47 , 48 …”
Section: Discussionmentioning
confidence: 99%